Hayes D, Condon F, Henry M, Duggan M, Mitchell T
Department of Medicine, Regional Hospital, Cork.
Ir Med J. 1993 Jul-Aug;86(4):133.
The use of sodium clodronate in the treatment of primary hyperparathyroidism is described. The drug successfully reduced the serum calcium but without improvement in the patients muscle and joint symptoms. It appears that mild degrees of hypercalcaemia have few clinical effects.
描述了氯膦酸钠在原发性甲状旁腺功能亢进治疗中的应用。该药物成功降低了血清钙,但患者的肌肉和关节症状并未改善。似乎轻度高钙血症几乎没有临床影响。